v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 353,375 $ 553,820
Cost of revenues 290,491 388,025
Gross profit 62,884 165,795
Operating expenses:    
Sales, general and administrative 1,352,758 801,144
Research and development 153,482 136,831
Total operating expenses 1,506,240 937,975
Operating loss (1,443,356) (772,180)
Other (expense) income:    
Interest expense (267,008) (740)
Interest income 6,653 8,458
Loss on change in fair value of warrant liability (148,766)
Loss on issuance of convertible note (322,359)
Other expense, net (115)
Total other (expense) income (731,480) 7,603
Provision for income taxes
Net loss (2,174,836) (764,577)
Dividend on preferred stock 54,192
Net loss attributable to common stockholders $ (2,120,644) $ (764,577)
Basic net loss per common share (in Dollars per share) $ (0.28) $ (0.16)
Diluted net loss per common share (in Dollars per share) $ (0.28) $ (0.16)
Weighted-average common shares outstanding, basic (in Shares) 7,657,229 4,823,125
Weighted-average common shares outstanding, diluted (in Shares) 7,657,229 4,823,125